Carolyn R. Bertozzi
Director, Eli Lilly and Company.
Companies
- Alnylam PharmaceuticalsBoard member Jan 9, 2023 to now1
- OmniAb, Inc.Board member Nov 3, 2022 to now2
- Eli Lilly and CompanyBoard member Feb 23, 2017 to now3
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY2,000 shares4$2.5M at $1,257.32Dec 8, 2025
Alnylam Pharmaceuticals ALNY775 shares5$182.6K at $235.58May 8, 2025- OmniAb, Inc. OABIW113,308 shares6$19.3K at $0.17Jun 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Exercised options 20,000 shares of OmniAb, Inc.6
- Nov 1, 2025Exercised options 17,769 shares of OmniAb, Inc.7
- Jun 17, 2025Exercised options 20,000 shares of OmniAb, Inc.8
- May 8, 2025Granted 775 shares of Alnylam Pharmaceuticals5
- Nov 1, 2024Exercised options 17,769 shares of OmniAb, Inc.9
- Jun 18, 2024Exercised options 20,000 shares of OmniAb, Inc.10
- Nov 1, 2023Exercised options 17,770 shares of OmniAb, Inc.11
- Jan 3, 2023Granted 53,308 shares of OmniAb, Inc.12
- Nov 16, 2020Granted 1,245 shares at $140.59 of Eli Lilly and Company13
- Nov 18, 2019Granted 1,534 shares at $114.07 of Eli Lilly and Company14
- Nov 19, 2018Granted 1,511 shares at $115.81 of Eli Lilly and Company15
- Nov 20, 2017Granted 1,763 shares at $83.18 of Eli Lilly and Company16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAROmniAb, Inc., Board member
- 3SEC EDGAREli Lilly and Company, Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Nov 3, 2025
- 8SEC EDGARForm 4 filed Jun 18, 2025
- 9SEC EDGARForm 4 filed Nov 1, 2024
- 10SEC EDGARForm 4 filed Jun 21, 2024
- 11SEC EDGARForm 4 filed Nov 1, 2023
- 12SEC EDGARForm 4 filed Jan 5, 2023
- 13SEC EDGARForm 4 filed Nov 18, 2020
- 14SEC EDGARForm 4 filed Nov 20, 2019
- 15SEC EDGARForm 4 filed Nov 20, 2018
- 16SEC EDGARForm 4 filed Nov 22, 2017